The lawyers and attorneys at The Hood National Law Group are currently taking Taxotere hair loss claims with possible cash settlements from a class action lawsuit. If you or someone you know has had hair loss from this type of chemotherapy drug contact us today for a free case review.
Taxotere (generic name: Docetaxel) is an intravenous injection used to treat mostly breast cancer patients but can also be used for neck, head or prostrate cancers. It should be noted that women who are planning on becoming pregnant should not use Taxotere as it may harm the fetus.
Taxotere is administered usually in a clinic or hospital over the course of an hour and usually for a 3 week term.
Sanofi-Aventis the maker of Taxotere gained FDA approval of its cancer fighting drug back in 1996.
It wasn’t until December of 2015 that the FDA forced the company to change its package label warning women of possible permanent hair loss known by its medical name alopecia (baldness).
However before the edits made to the Taxotere label it read: “hair generally grows back”. Failure to warn women of the possibility of permanent hair loss is the basis of this Taxotere lawsuit.
Taxotere Adverse Reactions:
From the Sanofi-Aventis website page for Taxotere reads: “Most common adverse reactions across all TAXOTERE indications are infections, neutropenia, anemia, febrile neutropenia, hypersensitivity, thrombocytopenia, neuropathy, dysgeusia, dyspnea, constipation, anorexia, nail disorders, fluid retention, asthenia, pain, nausea, diarrhea, vomiting, mucositis, alopecia, skin reactions, myalgia”
It shows that when women take Taxotere alone 3% may experience long-term alopecia.
Hair Loss Risk Increases with Other Cancer Drug Combinations:
But the figure rises to 6.3% of women who have taken chemo drug Taxotere in combinations with other cancer drugs such as Adriamycin and Cytoxan have experienced permanent hair loss.
Woman speaks out on her hair loss.
A stirring article from UK based The Telegraph tells the story of Shirley Ledlie who experienced permanent hair loss after the chemo drug “cocktail” containing Taxotere. “Something had gone drastically wrong with my hair follicles during treatment. What was supposed to be a temporary side-effect was actually going to be a permanent disfiguring feature in my life. I left the clinic that day in total denial and devoid of any femininity.” Read her story here: http://www.telegraph.co.uk/lifestyle/wellbeing/healthadvice/11841436/I-survived-cancer-but-drugs-left-me-with-permanent-alopecia.html
Taxotere Lawsuit Forming
It’s hard enough to have to deal with breast cancer, but add in the possibility of never having your hair grow back is unacceptable. We intend to hold Sanofi-Aventis accountable for not properly displaying or clearly notifying women of this terrible hair loss side effect. To join the Taxotere Class Action lawsuit – simply use the form on the right side of this page to start the evaluation.
The National Center for Biotechnology Information http://www.ncbi.nlm.nih.gov/pubmed/20471136